Circular RNAs in Cancer: Epigenetic Regulation, Dual Functions and Clinical Translation
BioFactors · 2026-05 · 52 (3)
DOI: 10.1002/biof.70109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioFactors, online erschienen am 14.05.2026. Verfasst von Yimao Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory for Cancer Systems Regulation and Clinical Translation, Shanghai Jiading District Central Hospital, Shanghai, China. Hauptthemen laut MEDLINE: RNA, Circular, Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 196 Literaturangaben.
Abstract (Originalsprache)
Circular RNAs (circRNAs), a class of non‐coding RNAs with a closed‐loop structure, have emerged as a focal point in cancer research due to their stability, tissue specificity, and high abundance in body fluids. This paper systematically elaborates on the dual roles of circRNAs in cancer. Specifically, they can act as tumor suppressors to inhibit tumor progression or as oncogenes to promote tumorigenesis. Their core mechanisms involve epigenetic regulation, including modulation of DNA methylation, histone post‐translational modifications, and functioning as miRNA sponges to affect target gene expression. CircRNAs regulate cancer hallmarks through these mechanisms, such as cell proliferation, apoptosis resistance, angiogenesis, and invasion‐metastasis. Additionally, due to their unique biological properties, circRNAs show great potential in cancer diagnosis and prognostic evaluation. Intervention strategies targeting the circRNA‐epigenetic axis, such as antisense oligonucleotides and CRISPR technology, provide new directions for cancer therapy. This study aims to deeply analyze the complex regulatory networks of circRNAs in tumorigenesis and progression, explore key challenges in their translation from basic research to clinical practice, and offer theoretical basis and practical references for understanding epigenetic dysregulation in cancer and developing novel diagnostic and therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory for Cancer Systems Regulation and Clinical Translation, Shanghai Jiading District Central Hospital, Shanghai, China.
- Second Clinical Medical College, Guangdong Medical University, Guangdong, China.
- Traditional Chinese Medicine (Innovation Institute of Integrated Traditional Chinese and Western Medicine), Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
- College of Pharmacy, Inner Mongolia Medical University, Inner Mongolia, China.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Yimao Wu, Meng-Yao Li
Zitieren
APA
Wu, Y., Chen, Z., Tang, F., Sun, W., Zhang, Q., & Li, M. Y. (2026). Circular RNAs in Cancer: Epigenetic Regulation, Dual Functions and Clinical Translation. BioFactors, 52(3). https://doi.org/10.1002/biof.70109
Vancouver
Wu Y, Chen Z, Tang F, Sun W, Zhang Q, Li MY. Circular RNAs in Cancer: Epigenetic Regulation, Dual Functions and Clinical Translation. BioFactors. 2026;52(3). doi:10.1002/biof.70109
BibTeX
@article{Wu2026,
author = {Wu, Yimao and Chen, Zichang and Tang, Feiyang and Sun, Wenlong and Zhang, Qian and Li, Meng-Yao},
title = {Circular RNAs in Cancer: Epigenetic Regulation, Dual Functions and Clinical Translation},
journal = {BioFactors},
year = {2026},
volume = {52},
number = {3},
doi = {10.1002/biof.70109}
}
EUVIMED